About TriAgenics
TriAgenics is a Healthcare company based in Redmond (United States) founded in 2016. Minimally invasive treatment for preventing wisdom teeth formation is developed. TriAgenics has raised $5.5 million across 2 funding rounds. The company has 2 employees. Its chief executive, as recorded, is Leigh Colby. TriAgenics offers products and services including Zero3™ TBA. Its focus areas include Life Sciences, Dental Disorders, Medical Devices and Therapeutic Devices. Its legal entity is TriAgenics, Inc. Its competitors include GO SMiLE, CERAMIR and DMAX America.
Company details
TriAgenics was founded in 2016 and is based in Redmond, United States. Operations focus on the development of a minimally invasive procedure targeted at tooth buds to halt wisdom teeth formation. Safety and efficacy have been evaluated through animal studies, with the treatment currently unapproved for human application. The company operates in the dental biotechnology sector.
- Headquarters Redmond, United States
- Employees 2
- SectorsHealthcare
- Website triagenics.com
- Social LinkedIn X Facebook
- Legal Name Triagenics, Inc
- Net Profit-$1.44 M (USD)-1as on Dec 31, 2023
- Total Equity Funding$5.5M (USD)
in 2 rounds
- Latest Funding Round$500K (USD), Series A
Apr 2025
- Employee Count2
Products & Services of TriAgenics
TriAgenics offers a comprehensive portfolio of products and services, including Zero3™ TBA.
Procedure to prevent wisdom teeth by warming tooth buds in animals.
Funding Insights of TriAgenics
TriAgenics has successfully raised a total of $5.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.5M
- Total Rounds 2
- Last Round Series A — $500,000
- First Round $5M
(Jan 2025)
All 2 funding rounds of TriAgenics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $500,000 | Series A | – | – | – |
| Jan 2025 | $5M | Series A | – | – | – |
People of TriAgenics
5 people are tracked at TriAgenics (2 in leadership, 3 in board & advisors); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Leigh Colby | CEO & President | Leadership |
Dave Watson | Chief of Operations | Leadership |
John Chopack, Jr. | Director | Board & advisors |
George Shahin | Director | Board & advisors |
Jeff Jacobs | Director | Board & advisors |
Complete people profiles for TriAgenics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TriAgenics
3 dated milestones of TriAgenics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded TriAgenics is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $500K.
Competitors of TriAgenics
TriAgenics has 3 listed competitors in our database. They include GO SMiLE, CERAMIR and DMAX America.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gosmile.com | 2002 | Emeryville, United States | Teeth whitening solutions | |||
| ceramirdental.com | 1987 | Chicago, United States | Dental consumables and instruments are developed and manufactured by CERAMIR. | |||
| dmaxamerica.com | 2020 | La Mirada, United States | Offers dental materials and CAD/CAM technology for clinic applications. |
Detailed competitors of TriAgenics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TriAgenics
The website of TriAgenics (triagenics.com) receives about 6.4K visits a month.
- Monthly visits6.4K
▼ 21.6% vs previous month
Top companies in Dental Disorders
3 companies that operate in the same segment as TriAgenics (Dental Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Custom 3D printed dental aligners are developed for teeth straightening. | 2017 | New York, New York, United States | USD 147.78 M | |||
Invisalign clear aligners and dental products are developed. | 1997 | Tempe, Arizona, United States | USD 101 M | 1,051 | ||
Optical equipment for micron-level surface geometry capture is offered. | 2011 | Waltham, Massachusetts, United States | USD 16.22 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Triagenics
Complete news archive for TriAgenics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TriAgenics
TriAgenics was founded in 2016 and raised its 1st funding round 9 years after it was founded.
TriAgenics is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Leigh Colby is the CEO of TriAgenics, as recorded in our data.
TriAgenics is a funded company, having raised a total of $5.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jan 2025.
TriAgenics has 2 employees.
TriAgenics was founded in 2016 and is based in Redmond, United States. Operations focus on the development of a minimally invasive procedure targeted at tooth buds to halt wisdom teeth formation. Safety and efficacy have been evaluated through animal studies, with the treatment currently unapproved for human application. The company operates in the dental biotechnology sector.
TriAgenics's top competitors include CERAMIR, GO SMiLE and DMAX America.
TriAgenics offers Zero3™ TBA.
TriAgenics operates through Triagenics, Inc.